ERBB2 and triple-negative breast carcinoma: Similarly, Notch signaling pathways are involved in cell proliferation, apoptosis, hypoxia, and epithelial-to-mesenchymal transition and were found to be overexpressed in HER2-positive and triple-negative breast cancer (64).